If true, the interactions between acrylamide and HSD3B SNPs for ovarian cancer [8] and between acrylamide and the CYP1B1 and CYP11A1 SNPs for breast cancer in the current study give some indications that acrylamide may interfere with progesterone metabolism. This evidence concerns the gene CYP11A1 and ovarian cancer.